Literature DB >> 16955461

Hepatitis C viral infection is not associated with Waldenström's macroglobulinemia.

Xavier Leleu1, Kelly O'Connor, Allen W Ho, Daniel D Santos, Robert Manning, Lian Xu, Evdoxia Hatjiharissi, Anne-Sophie Moreau, Andrew R Branagan, Zachary R Hunter, Elizabeth A Dimmock, Jacob Soumerai, Christopher Patterson, Irene Ghobrial, Steven P Treon.   

Abstract

While a familial predisposition may exist in up to 20% of patients with Waldenström's Macroglobulinemia (WM), the precipitating cause of this B-cell malignancy remains unknown in most patients. In previous studies, an association between hepatitis C virus (HCV) infection and WM has been suggested as etiological. This relationship has been the subject of debate, however, with some studies demonstrating increased incidence of HCV infection among WM patients and other studies showing no such association exists. This discordance might be attributable to the analytical method used, HCV antibody detection, which might be ineffective in patients with immunosuppression. We therefore analyzed the prevalence of HCV in a large population of WM patients utilizing both an HCV antibody detection immunoassay as well as qualitative polymerase chain reaction assay to directly detect HCV presence in serum samples. None of 100 randomly tested WM patients in this study tested positive for HCV by either analytical method. Our results therefore demonstrate a lack of association between HCV and WM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16955461     DOI: 10.1002/ajh.20724

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

Review 1.  Non-Hodgkin lymphoma and hepatitis C: where we are and what next?

Authors:  Mihály Sulyok; Mihály Makara; Eszter Újhelyi; István Vályi-Nagy
Journal:  Pathol Oncol Res       Date:  2014-10-02       Impact factor: 3.201

Review 2.  Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.

Authors:  Michiel van den Brand; J Han J M van Krieken
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

3.  Waldenstrom macroglobulinemia.

Authors:  Xavier Leleu; Aldo M Roccaro; Anne-Sophie Moreau; Sophie Dupire; Daniela Robu; Julie Gay; Evdoxia Hatjiharissi; Nicholas Burwik; Irene M Ghobrial
Journal:  Cancer Lett       Date:  2008-06-13       Impact factor: 8.679

Review 4.  Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.

Authors:  Luca Arcaini; Michele Merli; Stefano Volpetti; Sara Rattotti; Manuel Gotti; Francesco Zaja
Journal:  Clin Dev Immunol       Date:  2012-08-26

5.  An unusual case of Waldenstrom's macroglobulinemia presented with nasopharyngeal involvement.

Authors:  Vishwanath Sathyanarayanan; Umesh Das; Bs Shankaranand; Sumit Gupta; Naveen J Anvekar; Kc Lakshmaiah
Journal:  Ecancermedicalscience       Date:  2013-10-16

6.  Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.

Authors:  Charlene M McShane; Liam J Murray; Eric A Engels; Lesley A Anderson
Journal:  Br J Haematol       Date:  2013-11-26       Impact factor: 6.998

7.  Waldenström macroglobulinemia in hepatitis C: case report and review of the current literature.

Authors:  Ryan Nipp; Aaron Mitchell; Allyson Pishko; Ara Metjian
Journal:  Case Rep Oncol Med       Date:  2014-08-27

8.  Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.

Authors:  Xuejiao Yin; Lei Chen; Fengjuan Fan; Han Yan; Yuyang Zhang; Zhenli Huang; Chunyan Sun; Yu Hu
Journal:  Front Oncol       Date:  2020-09-10       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.